Finance

AP FACT CHECK: Claims from the Democratic debate

Twelve Democrats seeking the presidency tussled Tuesday night in a wide-ranging debate featuring the largest number of qualifying candidates on the same stage. Here’s a look at how some of their claims from Westerville, Ohio, stack up with the facts: JULIAN CASTRO, former U.S. housing secretary: “Ohio, Michigan, and Pennsylvania actually in the latest jobs […]

AP FACT CHECK: Claims from the Democratic debate Read More »

What’s Really in the Trade Deal Trump Announced With China

President Trump portrayed the “Phase 1” agreement he announced on Friday with China with typical fanfare, describing the pact as “massive” and “the largest contract” ever signed. “We made a fantastic deal,” Mr. Trump said during remarks on Tuesday at the White House. There are good reasons to be skeptical about those claims. The deal

What’s Really in the Trade Deal Trump Announced With China Read More »

German 5G rules avoid Huawei ban; US warns on intel sharing

Germany released draft security guidelines on Tuesday for next generation wireless networks that stopped short of banning Huawei, as the U.S. warned again it would reconsider intelligence sharing with allies that use the Chinese company’s equipment. The Federal Network Agency catalog of conditions for suppliers of new 5G networks include requiring certification of critical components

German 5G rules avoid Huawei ban; US warns on intel sharing Read More »

UnitedHealth hikes annual forecast, offers glimpse into 2020

UnitedHealth Group raised its 2019 forecast and detailed another better-than-expected quarter Tuesday, but shares soared after company leaders mentioned next year’s growth prospects. CEO David Wichmann told analysts it would be “reasonable and prudent” for them to set initial expectations for core operating performance at the lower end of UnitedHealth’s long-term goal of 13% to

UnitedHealth hikes annual forecast, offers glimpse into 2020 Read More »

Higher 3Q profit, improved outlook for Johnson & Johnson

Johnson & Johnson’s third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world’s biggest maker of health care products also raised its financial forecast for the year, and its shares jumped more than 2% in

Higher 3Q profit, improved outlook for Johnson & Johnson Read More »